This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).
This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC). Blood, saliva, stool, and urine samples will be collected periodically during patient visits, mail-home kit (collected locally), or via remote phlebotomy at a place directed by the subject. Bile and bile duct cells will be collected during clinically necessary Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures being performed at Mayo Clinic for clinical reasons. Anticipated research will focus on multi-omics assessments of biospecimens to better define how these diseases start and progress in order to develop novel tests for early detection of complication and better disease prognostication.
Study Type
OBSERVATIONAL
Enrollment
9,150
Mayo Clinic
Rochester, Minnesota, United States
RECRUITINGNumber of participants in the study.
Number of participants in the study.
Time frame: 20 years
Number of samples collected (per type).
Number of samples collected (blood, urine, stool, bile, bile duct cells)
Time frame: 20 years
Number of clinical phenotypes and/or endpoints observed (per category)
Number of clinical phenotypes and/or endpoints observed (i.e. disease progression, liver cancer development)
Time frame: 20 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.